Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. META
4. DPZ
5. IBM
6. CNC
7. KFY
8. SPY
9. MU
10. ENRD

Go back to Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
(NASDAQ: GCTK) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High $ 
Open $0.36    52 Week Low $ 
Day High $0.36    P/E N/A 
Day Low $0.36    EPS $ 
Volume 36,699       

(NASDAQ: GCTK) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High $ 
Open $0.36    52 Week Low $ 
Day High $0.36    P/E N/A 
Day Low $0.36    EPS $ 
Volume 36,699